Patents by Inventor Dejun Xuan

Dejun Xuan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8048984
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Grant
    Filed: December 1, 2008
    Date of Patent: November 1, 2011
    Assignee: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Publication number: 20110262390
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Application
    Filed: May 23, 2011
    Publication date: October 27, 2011
    Applicant: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Patent number: 7951372
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Grant
    Filed: August 31, 2007
    Date of Patent: May 31, 2011
    Assignee: Wyeth LLC
    Inventors: Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Publication number: 20100260767
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Application
    Filed: January 15, 2010
    Publication date: October 14, 2010
    Inventors: Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Publication number: 20090227772
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Application
    Filed: December 1, 2008
    Publication date: September 10, 2009
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Patent number: 7585646
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: September 8, 2009
    Assignee: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Patent number: 7459533
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: December 2, 2008
    Assignee: Genetics Institute, LLC.
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Patent number: 7307161
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Grant
    Filed: April 28, 2000
    Date of Patent: December 11, 2007
    Assignee: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Patent number: 7279559
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Grant
    Filed: September 27, 2002
    Date of Patent: October 9, 2007
    Assignee: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Publication number: 20050238648
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Application
    Filed: June 20, 2005
    Publication date: October 27, 2005
    Inventors: Kenneth Jacobs, Debra Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Patent number: 6939545
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Grant
    Filed: February 25, 2002
    Date of Patent: September 6, 2005
    Assignee: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Publication number: 20050158760
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Application
    Filed: December 17, 2004
    Publication date: July 21, 2005
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Publication number: 20050153400
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Application
    Filed: December 17, 2004
    Publication date: July 14, 2005
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Publication number: 20030157106
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Application
    Filed: September 27, 2002
    Publication date: August 21, 2003
    Applicant: Wyeth
    Inventors: Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Publication number: 20030099649
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Application
    Filed: February 25, 2002
    Publication date: May 29, 2003
    Inventors: Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan